ISHARES MSCI ACWI EX US FINLS ETF
AXFN
AXFN was delisted on the 25th of March, 2014.
7 hedge funds and large institutions have $3.1M invested in ISHARES MSCI ACWI EX US FINLS ETF in 2014 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
19% more capital invested
Capital invested by funds: $2.6M → $3.1M (+$497K)
0% more funds holding
Funds holding: 7 → 7 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$361K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$224K |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$22.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.9K |
| 2 |
Morgan Stanley
New York
|
-$1.04K |
AXFN Hedge Fund Activity: Q1 2014 in Review
7 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in ISHARES MSCI ACWI EX US FINLS ETF (AXFN) for Q1 2014, worth a combined $3.1M — up 19% from $2.6M a quarter earlier.
Fund positioning in AXFN was balanced in Q1 2014: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $361K. The largest seller was Tower Research Capital (TRC), cutting an estimated $1.9K.
- 7 institutional investors held ISHARES MSCI ACWI EX US FINLS ETF (AXFN) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $3.1M of ISHARES MSCI ACWI EX US FINLS ETF stock for Q1 2014, up 19% quarter-over-quarter.
- 0 funds opened new ISHARES MSCI ACWI EX US FINLS ETF positions in Q1 2014 and 0 closed out.
- The largest ISHARES MSCI ACWI EX US FINLS ETF buyer in Q1 2014 was Susquehanna International Group, an estimated $361K added.
- The largest ISHARES MSCI ACWI EX US FINLS ETF seller in Q1 2014 was Tower Research Capital (TRC), an estimated $1.9K sold.
Based on aggregated 13F filings for Q1 2014.